ABBOTT LABORATORIES (ABT) Earnings
ABBOTT LABORATORIES's most recently reported earnings, recent earnings filings (8-K) and headline annual financials, sourced from SEC EDGAR.
Last reported earnings
Jul 16, 2026
From the latest earnings 8-K
Revenue · FY2025
$44.33B
▲ 5.7%YoY
Diluted EPS · FY2025
$3.72
▼ 51.3%YoY
Reported earnings dates are based on the latest 8-K (Item 2.02) filings. The next earnings date is an estimate projected from ABT's historical reporting pattern, not a company-confirmed date.
Headline financials
| Period | Revenue | Net income | Gross profit | Dil. EPS |
|---|---|---|---|---|
| FY2025 | $44.33B | $6.52B | — | $3.72 |
| FY2024 | $41.95B | $13.40B | — | $7.64 |
| FY2023 | $40.11B | $5.72B | — | $3.26 |
| FY2022 | $43.65B | $6.93B | — | $3.91 |
Recent earnings filings
| Filed | Form | Accession |
|---|---|---|
| Jul 16, 2026 | 8-K (2.02) | 0001628280-26-048377EDGAR |
| Apr 16, 2026 | 8-K (2.02) | 0001628280-26-025365EDGAR |
| Jan 22, 2026 | 8-K (2.02) | 0001628280-26-002982EDGAR |
| Oct 15, 2025 | 8-K (2.02) | 0001628280-25-045049EDGAR |
| Jul 17, 2025 | 8-K (2.02) | 0001628280-25-035135EDGAR |
| Apr 16, 2025 | 8-K (2.02) | 0001628280-25-017924EDGAR |
| Jan 22, 2025 | 8-K (2.02) | 0001628280-25-002092EDGAR |
| Oct 16, 2024 | 8-K (2.02) | 0001628280-24-042893EDGAR |
Never miss a ABT filing.
Get an email when ABT files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Aug 29, 2026Source: SEC EDGAR.